ライフサイエンスコーパス: retinamide

1 halene carboxylic acid or N-(4-hydroxyphenyl)retinamide.

2 tic retinoid, fenretinide N-(4-hydroxyphenyl)retinamide.

3 tic retinoid, fenretinide N-(4-hydroxyphenyl)retinamide.

4 The retinoid N-(4-hydroxyphenyl)retinamide (4-HPR also known as fenretinide) is a potent

5 We explored efficacy of N-(4-hydroxyphenyl) retinamide (4-HPR) and (-)-epigallocatechin-3-gallate (E

6 e synergistic actions of N-(4-hydroxyphenyl) retinamide (4-HPR) and paclitaxel (PTX) to control the g

7 We identify N-(4-hydroxyphenyl) retinamide (4-HPR) as effective in protecting against DE

8 of breast cancer cells to N-(4-hydroxyphenyl)retinamide (4-HPR) by suppressing nitric oxide productio

9 etic retinoid fenretinide N-(4-hydroxyphenyl)retinamide (4-HPR) has shown promise for treating breast

10 of the synthetic retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) in tumor cells.

11 The synthetic retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) induces apoptosis in a variety of cel

12 N-(4-Hydroxyphenyl) retinamide (4-HPR) is a synthetic retinoid that has show

13 s induced by fenretinide (N-(4-hydroxyphenyl)retinamide (4-HPR)).

14 N-(4-Hydroxyphenyl)retinamide (4-HPR), a dihydroceramide synthase activator

15 N-(4-Hydroxyphenyl)retinamide (4-HPR), a retinoic acid analog, induces apop

16 etic retinoid, N-(4-hydroxyphenyl)-all-trans-retinamide (4-HPR), on the induction of prostate cancer

17 romolar concentrations of N-(4-hydroxyphenyl)retinamide (4-HPR), which downmodulates cyclin D1, induc

18 acological agents such as N-(4-hydroxyphenyl)retinamide (4-HPR, fenretinide), by treatment with sphin

19 th the synthetic retinoid N-(4-hydroxyphenyl)retinamide (4-HPR; CON+/-4HPR group; 1,173 )microg of 4-

20 The retinoid N-(4-hydroxyphenyl)retinamide (4-HPR; fenretinide) is cytotoxic to a variet

21 h the cytotoxic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR; fenretinide) may decrease relapse.

22 N-(4-Methoxyphenyl)retinamide (4-MPR) and 4-Oxo-N-(4-methoxyphenyl)retinami

23 not the closely related N-(4-methoxyphenyl) retinamide (4-MPR) could reduce viral RNA levels and tit

24 Mean +/- SD Cp of 4-HPR, N-(4-methoxyphenyl) retinamide (4-MPR), and retinol after 1 month of 4-HPR w

25 tabolites of 4-HPR, 4-oxo-N-(4-hydroxyphenyl)retinamide (4-oxo-4-HPR) showed the highest inhibitory e

26 inamide (4-MPR) and 4-Oxo-N-(4-methoxyphenyl)retinamide (4-oxo-4-MPR) had minimal effects on DES acti

27 N-(4-hydroxyphenyl) retinamide [4-HPR], a synthetic retinoid, has been shown

28 All-trans-N-(4-hydroxyphenyl)retinamide (4HPR) belongs to a new group of retinoids th

29 by the synthetic retinoid N-(4-hydroxyphenyl)retinamide (4HPR) has been documented in vitro in variou

30 The synthetic retinoid N-(4-hydroxyphenyl)retinamide (4HPR) has been shown to induce apoptosis in

31 The synthetic retinoid N-(4-hydroxyphenyl)retinamide (4HPR) has shown potential as a chemopreventi

32 The synthetic retinoid N-(4-hydroxyphenyl)retinamide (4HPR) is being examined in both chemoprevent

33 N-(4-Hydroxyphenyl)retinamide (4HPR) is currently used in cancer prevention

34 Fenretinide (N-[4-hydroxyphenyl]retinamide (4HPR)) is a retinoid analogue with antitumor

35 In contrast, N-(4-hydroxyphenyl)retinamide (4HPR), a reported transcriptional activator

36 N-(4-hydroxyphenyl)retinamide (4HPR), a synthetic retinoid effective in can

37 cells was comparable with N-(4-hydroxyphenyl)retinamide (4HPR).

38 another biologic agent, N-(4-hydroxyphenyl) retinamide (4HPR, fenretinide) with rituximab against a

39 e growth inhibited by RA, N-(4-hydroxyphenyl)retinamide, and 4-oxoretinol, only the 4-oxoretinol is g

40 However, N-(4-hydroxyphenyl)-retinamide, another apoptosis-inducing retinoid, and ret

41 to its major metabolite, N-[4-methoxyphenyl]retinamide, as well as several other metabolites of 4-HP

42 ltiplicity of PIN, whereas 4-(hydroxyphenyl) retinamide at 392 or 784 mg/kg diet, did not have an inh

43 arsenic trioxide (ARS), N-(4-hydroxyphenyl) retinamide (HPR) or dithiophene (NSC656240 (NSC)).

44 N-(4-hydroxyphenyl)retinamide (HPR) potently and reversibly reduces serum r

45 the synthetic retinoid, N-(4-hydroxyphenyl) retinamide (HPR), induces HL60 cells to undergo apoptosi

46 everal cell lines against N-(4-hydroxyphenyl)retinamide (HPR)-induced apoptosis.

47 derivative fenretinide (N-(4-hydroxyphenyl) retinamide; HPR) exerts therapeutic effects in mouse mod

48 led retinoic acid (RA) or N-(4-hydroxyphenyl)retinamide, indicating that these drugs enhance [3H]reti

49 N-(4-hydroxyphenyl) retinamide ( inverted question mark4-HPR, Fenretinide; R

50 Mean N-4-hydroxyphenyl retinamide plasma level (day 7, steady-state concentrati

51 rs activities of novel C-4 heteroaryl 13-cis-retinamides that modulate Mnk-eIF4E and AR signaling are

52 N-(4-Hydroxyphenyl)retinamide up-regulated ELF3, c-Jun, Rb2/p130, JAK1, p67

53 The synthetic retinoid N-(4-hydroxyphenyl)retinamide, which does not bind effectively to RAR-beta,

54 is-retinoic acid (9cRA) and 4-(hydroxyphenyl)retinamide, which in previous studies have shown promisi